Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.7 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |